What Leducq Foundation does

Leducq Foundation is an international charitable organization that funds collaborative cardiovascular disease research through transatlantic research networks. Founded in 1996 and operationalized in 2005 with headquarters at 265 Franklin Street in Boston, the foundation operates additional offices in Houston (registered address of Leducq Foundation for Cardiovascular Research) and New York, and maintains a lean staff of approximately 10-15 people led by President David Tancredi, MD, PhD; Chief Scientific Officer David Milan, MD; Chief Operating Officer Alex Tancredi; and Chief Financial Officer Rosemary McGreevy. Its core offering is the International Networks of Excellence Program, a competitive grant mechanism that funds multi-year collaborative consortia pairing North American and European investigators at institutions such as Stanford, UCSF, NYU Grossman, and Karolinska Institutet, with research oversight provided by a Scientific Advisory Committee that includes Dr. Eugene Braunwald. The foundation has built a portfolio of more than 90 funded networks covering atherosclerosis, heart failure, stroke, atrial fibrillation, cardiac regeneration, vascular biology, and hypertension.

The foundation supplements the Networks program with a dedicated Rheumatic Heart Disease initiative comprising the Acute Rheumatic Fever Biomarker Project, a Group A Strep Immune Correlates of Protection program (with active 2022-2023 application cycle), Group A Strep Vaccine Development, and a Polymeric Heart Valve project. Funding is distributed via competitive application review rather than commercial pricing, and the foundation operates as a non-profit entity funded by endowment investment returns, with grantmaking reaching academic and medical researchers across 16+ countries in North America, Europe, and Oceania. Distribution channels are non-commercial: a primary website (fondationleducq.org), an email newsletter for grant information and research highlights, academic conference presentations by funded networks, and peer-reviewed publications.

The business model is grantmaking, not product commercialization: revenue is generated from endowment investment returns and philanthropic contributions rather than from sales of goods or services, and the organization holds no patents, no trademarks of commercial significance, and no disclosed APIs or technology platforms. Strategic emphasis is on scientific credibility, network curation, and long-term funding commitments to enable sustained international collaboration rather than on revenue growth, market share, or operational scale-up.

Name

Leducq Foundation

Legal name

Leducq Foundation for Cardiovascular Research

Website

https://fondationleducq.org

Company type

Private

Founded year

2005

Operating status

Operating

Short description

Leducq Foundation is an international charitable organization, headquartered in Boston, that funds transatlantic collaborative research networks in cardiovascular disease through competitive grant programs, serving academic and medical researchers across 16+ countries.

Ownership category

akta.pro rank

Product category

Charitable Medical Research Grant Funding

NAICS

Grantmaking Foundations (813211), Voluntary Health Organizations (813212), Grantmaking and Giving Services (81321)

akta.pro primary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

akta.pro secondary industries

Research & Science Grantmaking Foundations (BPAGAKAI), Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

Keywords

• Cardiovascular research funding
• Transatlantic research networks
• Medical research grants
• Collaborative research funding
• Rheumatic heart disease

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Others, Operations, Marketing or Sales

Revenue model

1. Philanthropic funding and endowment distributions: The Leducq Foundation operates as an international charitable organization funded by endowments and philanthropic contributions. Revenue is generated from investment returns on the foundation's endowment and is distributed as research grants to fund cardiovascular disease research networks.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Leducq Foundation is an international charitable organization that funds collaborative cardiovascular disease research by awarding multi-year grants to transatlantic teams of investigators from academic and medical institutions in North America and Europe. Its flagship offering is the International Networks of Excellence Program, supplemented by a dedicated Rheumatic Heart Disease Program covering biomarker discovery, Group A Streptococcus vaccine development, and polymeric heart valve projects. The foundation does not sell products or services; instead, it distributes endowment-derived funds as research grants administered through competitive applications.

Product overview

The Leducq Foundation operates as an international charitable organization funding collaborative cardiovascular research through its core International Networks of Excellence Program. The foundation establishes transatlantic research consortia bringing together investigators from North America and Europe to study cardiovascular disease mechanisms, with a particular emphasis on understanding disease pathways and developing therapeutic approaches. In addition to the Networks of Excellence Program, the foundation supports a dedicated Rheumatic Heart Disease Program. The foundation's portfolio includes over 90 funded research networks spanning topics such as atherosclerosis, heart failure, cardiac regeneration, arrhythmias, stroke, and vascular biology.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Over 80 funded research networks addressing various aspects of cardiovascular disease

Named customers4 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Simons Foundation: The Simons Foundation operates as a major private philanthropic funder of scientific research across multiple disciplines, including biomedical sciences; it is a direct peer in operating model — private charitable foundation distributing competitive research grants.
• Doris Duke Charitable Foundation: The Doris Duke Charitable Foundation funds medical research through competitive grant programs to leading academic investigators; it is a directly comparable peer as a private medical research grantmaker with a similar endowment-driven funding model.

Broad incumbents

• American Heart Association: The AHA is the largest U.S. nonprofit funder of cardiovascular research and a parallel grantmaking organization operating at much larger scale; it is broadly comparable as a cardiovascular research funder but lacks Leducq's transatlantic-only network structure.
• Howard Hughes Medical Institute: HHMI is a large biomedical research organization that funds individual investigators and research programs across cardiovascular and related life sciences; it is a broad incumbent comparable to Leducq in mission but operates an in-house research model.
• Gates Foundation: The Bill & Melinda Gates Foundation is the world's largest private charitable foundation and funds significant cardiovascular and global health research; it is a broad incumbent in the same space, though its focus skews toward infectious disease and global health equity.
• British Heart Foundation: The BHF is the UK's leading cardiovascular research charity, funding investigator-led and program grants in heart and circulatory disease; it is highly comparable to Leducq as a cardiovascular-specific grantmaker but is geographically restricted to UK institutions.
• Wellcome Trust: Wellcome is a major global health research foundation funding biomedical and cardiovascular science through large grants and investigator awards, comparable in operating model as a private charitable grantmaker though substantially larger and broader in scope.
• Novo Nordisk Foundation: The Novo Nordisk Foundation is a large European philanthropic foundation that funds biomedical and cardiovascular research; it is comparable in mission to Leducq but operates at substantially larger scale and across multiple therapeutic areas.

Regional players

• European Research Council: The ERC is the leading European public funder of investigator-driven frontier research across all scientific fields including cardiovascular science; it is comparable as a competitive research grantmaker but is publicly funded and geographically restricted to Europe.

Emerging players

• Chan Zuckerberg Initiative (Bio): CZI's science program funds biomedical research through the Chan Zuckerberg Biohub and investigator grants; it is an emerging peer in private biomedical research philanthropy, with partial overlap in funding investigator-led cardiovascular-adjacent work.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/FondationLeducq

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Leducq Foundation